unknown
Stage
About
Exit071 develops proprietary microfluidic technology for efficient isolation and molecular analysis of exosomes, enabling high-throughput biomarker discovery and accelerating drug development.
Explore Exit071's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.